Global Molecular Quality Controls Market

Molecular Quality Controls Comprehensive Study by Type (Independent, Instrument Specific (DNA Sequencing)), Application (Infectious Diseases, Oncology, Genetic Tests, Other), End Users (IVD Manufacturers, Research Institute), Analyte Type (Single Analyte, Multianalyte) Players and Region - Global Market Outlook to 2026

Molecular Quality Controls Market by XX Submarkets | Forecast Years 2022-2027 | CAGR: 10.4%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Molecular quality control is method in which concerns with manufacturing, designing and selling products for molecular diagnostic testing. Such quality control methods plays important role in diagnostic testing for inherited disease, pharmaceutics and infectious disease. Rising investment Quality Assessment Leading to wide adoption of third party quality controls, which in turn supplement the very market.
According to AMA, the market for Molecular Quality Controls is expected to register a CAGR of 10.4% during the forecast period to 2026. This growth is primarily driven by High Demand for External Quality Assessment Leading to Wide Adoption of Third Party Quality Controls and Rise in Numbers of Certified Clinical Laboratories.

Globally, a noticeable market trend is evident Growing Focus on Establishing Quality in Molecular Laboratory. The Health Care Supplies sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as SeraCare Life Sciences Inc. (United States), ZeptoMetrix Corporation (United States), Bio-Rad Laboratories Inc. (United States), Microbiologics Inc. (United States), Thermo Fisher Scientific (United States), Maine Molecular Quality Controls Inc. (United States) and Abbott Laboratories (United States) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Regulatory Insights:
Food and Drug Administration body in the United States regulates MDx tests that qualify as products developed by industry as medical and IVD devices, including test kits, quality-control materials, and analyte-specific and reagents (ASRs) (21 CFR Part 809; 21 CFR Part 820.

Market Drivers
  • High Demand for External Quality Assessment Leading to Wide Adoption of Third Party Quality Controls
  • Rise in Numbers of Certified Clinical Laboratories

Market Trend
  • Growing Focus on Establishing Quality in Molecular Laboratory

Restraints
  • High Cost Involved in Quality Control
  • Lack of Favorable Reimbursement Policy for Molecular Tests

Opportunities
Growing Demand for Multi-Analyte Controls and Making Regulatory Frameworks Flexible and Focus on Built Up Favorable Environment for Such Tests
Challenges
Budgetary Constraints in Hospitals and Laboratories and Lack of Regulatory Clinical Laboratory Certification Policies in Emerging Countries

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Molecular Quality Controls Study Sheds Light on
— The Molecular Quality Controls Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Molecular Quality Controls industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Molecular Quality Controls industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Independent
  • Instrument Specific (DNA Sequencing)
By Application
  • Infectious Diseases
  • Oncology
  • Genetic Tests
  • Other
By End Users
  • IVD Manufacturers
  • Research Institute

By Analyte Type
  • Single Analyte
  • Multianalyte

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Demand for External Quality Assessment Leading to Wide Adoption of Third Party Quality Controls
      • 3.2.2. Rise in Numbers of Certified Clinical Laboratories
    • 3.3. Market Challenges
      • 3.3.1. Budgetary Constraints in Hospitals and Laboratories
      • 3.3.2. Lack of Regulatory Clinical Laboratory Certification Policies in Emerging Countries
    • 3.4. Market Trends
      • 3.4.1. Growing Focus on Establishing Quality in Molecular Laboratory
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Molecular Quality Controls, by Type, Application, End Users, Analyte Type and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Molecular Quality Controls (Value)
      • 5.2.1. Global Molecular Quality Controls by: Type (Value)
        • 5.2.1.1. Independent
        • 5.2.1.2. Instrument Specific (DNA Sequencing)
      • 5.2.2. Global Molecular Quality Controls by: Application (Value)
        • 5.2.2.1. Infectious Diseases
        • 5.2.2.2. Oncology
        • 5.2.2.3. Genetic Tests
        • 5.2.2.4. Other
      • 5.2.3. Global Molecular Quality Controls by: End Users (Value)
        • 5.2.3.1. IVD Manufacturers
        • 5.2.3.2. Research Institute
      • 5.2.4. Global Molecular Quality Controls by: Analyte Type (Value)
        • 5.2.4.1. Single Analyte
        • 5.2.4.2. Multianalyte
      • 5.2.5. Global Molecular Quality Controls Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Molecular Quality Controls: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. SeraCare Life Sciences Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. ZeptoMetrix Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Bio-Rad Laboratories Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Microbiologics Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Thermo Fisher Scientific (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Maine Molecular Quality Controls Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abbott Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Molecular Quality Controls Sale, by Type, Application, End Users, Analyte Type and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Molecular Quality Controls (Value)
      • 7.2.1. Global Molecular Quality Controls by: Type (Value)
        • 7.2.1.1. Independent
        • 7.2.1.2. Instrument Specific (DNA Sequencing)
      • 7.2.2. Global Molecular Quality Controls by: Application (Value)
        • 7.2.2.1. Infectious Diseases
        • 7.2.2.2. Oncology
        • 7.2.2.3. Genetic Tests
        • 7.2.2.4. Other
      • 7.2.3. Global Molecular Quality Controls by: End Users (Value)
        • 7.2.3.1. IVD Manufacturers
        • 7.2.3.2. Research Institute
      • 7.2.4. Global Molecular Quality Controls by: Analyte Type (Value)
        • 7.2.4.1. Single Analyte
        • 7.2.4.2. Multianalyte
      • 7.2.5. Global Molecular Quality Controls Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Molecular Quality Controls: by Type(USD Million)
  • Table 2. Molecular Quality Controls Independent , by Region USD Million (2015-2020)
  • Table 3. Molecular Quality Controls Instrument Specific (DNA Sequencing) , by Region USD Million (2015-2020)
  • Table 4. Molecular Quality Controls: by Application(USD Million)
  • Table 5. Molecular Quality Controls Infectious Diseases , by Region USD Million (2015-2020)
  • Table 6. Molecular Quality Controls Oncology , by Region USD Million (2015-2020)
  • Table 7. Molecular Quality Controls Genetic Tests , by Region USD Million (2015-2020)
  • Table 8. Molecular Quality Controls Other , by Region USD Million (2015-2020)
  • Table 9. Molecular Quality Controls: by End Users(USD Million)
  • Table 10. Molecular Quality Controls IVD Manufacturers , by Region USD Million (2015-2020)
  • Table 11. Molecular Quality Controls Research Institute , by Region USD Million (2015-2020)
  • Table 12. Molecular Quality Controls: by Analyte Type(USD Million)
  • Table 13. Molecular Quality Controls Single Analyte , by Region USD Million (2015-2020)
  • Table 14. Molecular Quality Controls Multianalyte , by Region USD Million (2015-2020)
  • Table 15. South America Molecular Quality Controls, by Country USD Million (2015-2020)
  • Table 16. South America Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 17. South America Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 18. South America Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 19. South America Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 20. Brazil Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 21. Brazil Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 22. Brazil Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 23. Brazil Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 24. Argentina Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 25. Argentina Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 26. Argentina Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 27. Argentina Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 28. Rest of South America Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 29. Rest of South America Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 30. Rest of South America Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 31. Rest of South America Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 32. Asia Pacific Molecular Quality Controls, by Country USD Million (2015-2020)
  • Table 33. Asia Pacific Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 34. Asia Pacific Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 35. Asia Pacific Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 36. Asia Pacific Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 37. China Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 38. China Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 39. China Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 40. China Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 41. Japan Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 42. Japan Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 43. Japan Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 44. Japan Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 45. India Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 46. India Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 47. India Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 48. India Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 49. South Korea Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 50. South Korea Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 51. South Korea Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 52. South Korea Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 53. Taiwan Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 54. Taiwan Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 55. Taiwan Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 56. Taiwan Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 57. Australia Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 58. Australia Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 59. Australia Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 60. Australia Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 61. Rest of Asia-Pacific Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 62. Rest of Asia-Pacific Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 63. Rest of Asia-Pacific Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 64. Rest of Asia-Pacific Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 65. Europe Molecular Quality Controls, by Country USD Million (2015-2020)
  • Table 66. Europe Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 67. Europe Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 68. Europe Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 69. Europe Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 70. Germany Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 71. Germany Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 72. Germany Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 73. Germany Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 74. France Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 75. France Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 76. France Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 77. France Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 78. Italy Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 79. Italy Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 80. Italy Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 81. Italy Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 82. United Kingdom Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 83. United Kingdom Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 84. United Kingdom Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 85. United Kingdom Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 86. Netherlands Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 87. Netherlands Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 88. Netherlands Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 89. Netherlands Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 90. Rest of Europe Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 91. Rest of Europe Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 92. Rest of Europe Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 93. Rest of Europe Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 94. MEA Molecular Quality Controls, by Country USD Million (2015-2020)
  • Table 95. MEA Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 96. MEA Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 97. MEA Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 98. MEA Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 99. Middle East Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 100. Middle East Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 101. Middle East Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 102. Middle East Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 103. Africa Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 104. Africa Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 105. Africa Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 106. Africa Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 107. North America Molecular Quality Controls, by Country USD Million (2015-2020)
  • Table 108. North America Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 109. North America Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 110. North America Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 111. North America Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 112. United States Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 113. United States Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 114. United States Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 115. United States Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 116. Canada Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 117. Canada Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 118. Canada Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 119. Canada Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 120. Mexico Molecular Quality Controls, by Type USD Million (2015-2020)
  • Table 121. Mexico Molecular Quality Controls, by Application USD Million (2015-2020)
  • Table 122. Mexico Molecular Quality Controls, by End Users USD Million (2015-2020)
  • Table 123. Mexico Molecular Quality Controls, by Analyte Type USD Million (2015-2020)
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Molecular Quality Controls: by Type(USD Million)
  • Table 132. Molecular Quality Controls Independent , by Region USD Million (2021-2026)
  • Table 133. Molecular Quality Controls Instrument Specific (DNA Sequencing) , by Region USD Million (2021-2026)
  • Table 134. Molecular Quality Controls: by Application(USD Million)
  • Table 135. Molecular Quality Controls Infectious Diseases , by Region USD Million (2021-2026)
  • Table 136. Molecular Quality Controls Oncology , by Region USD Million (2021-2026)
  • Table 137. Molecular Quality Controls Genetic Tests , by Region USD Million (2021-2026)
  • Table 138. Molecular Quality Controls Other , by Region USD Million (2021-2026)
  • Table 139. Molecular Quality Controls: by End Users(USD Million)
  • Table 140. Molecular Quality Controls IVD Manufacturers , by Region USD Million (2021-2026)
  • Table 141. Molecular Quality Controls Research Institute , by Region USD Million (2021-2026)
  • Table 142. Molecular Quality Controls: by Analyte Type(USD Million)
  • Table 143. Molecular Quality Controls Single Analyte , by Region USD Million (2021-2026)
  • Table 144. Molecular Quality Controls Multianalyte , by Region USD Million (2021-2026)
  • Table 145. South America Molecular Quality Controls, by Country USD Million (2021-2026)
  • Table 146. South America Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 147. South America Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 148. South America Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 149. South America Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 150. Brazil Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 151. Brazil Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 152. Brazil Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 153. Brazil Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 154. Argentina Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 155. Argentina Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 156. Argentina Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 157. Argentina Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 158. Rest of South America Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 159. Rest of South America Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 160. Rest of South America Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 161. Rest of South America Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 162. Asia Pacific Molecular Quality Controls, by Country USD Million (2021-2026)
  • Table 163. Asia Pacific Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 164. Asia Pacific Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 165. Asia Pacific Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 166. Asia Pacific Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 167. China Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 168. China Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 169. China Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 170. China Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 171. Japan Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 172. Japan Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 173. Japan Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 174. Japan Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 175. India Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 176. India Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 177. India Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 178. India Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 179. South Korea Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 180. South Korea Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 181. South Korea Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 182. South Korea Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 183. Taiwan Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 184. Taiwan Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 185. Taiwan Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 186. Taiwan Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 187. Australia Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 188. Australia Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 189. Australia Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 190. Australia Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 191. Rest of Asia-Pacific Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 192. Rest of Asia-Pacific Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 193. Rest of Asia-Pacific Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 194. Rest of Asia-Pacific Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 195. Europe Molecular Quality Controls, by Country USD Million (2021-2026)
  • Table 196. Europe Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 197. Europe Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 198. Europe Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 199. Europe Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 200. Germany Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 201. Germany Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 202. Germany Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 203. Germany Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 204. France Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 205. France Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 206. France Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 207. France Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 208. Italy Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 209. Italy Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 210. Italy Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 211. Italy Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 212. United Kingdom Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 213. United Kingdom Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 214. United Kingdom Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 215. United Kingdom Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 216. Netherlands Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 217. Netherlands Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 218. Netherlands Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 219. Netherlands Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 220. Rest of Europe Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 221. Rest of Europe Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 222. Rest of Europe Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 223. Rest of Europe Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 224. MEA Molecular Quality Controls, by Country USD Million (2021-2026)
  • Table 225. MEA Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 226. MEA Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 227. MEA Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 228. MEA Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 229. Middle East Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 230. Middle East Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 231. Middle East Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 232. Middle East Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 233. Africa Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 234. Africa Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 235. Africa Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 236. Africa Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 237. North America Molecular Quality Controls, by Country USD Million (2021-2026)
  • Table 238. North America Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 239. North America Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 240. North America Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 241. North America Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 242. United States Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 243. United States Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 244. United States Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 245. United States Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 246. Canada Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 247. Canada Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 248. Canada Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 249. Canada Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 250. Mexico Molecular Quality Controls, by Type USD Million (2021-2026)
  • Table 251. Mexico Molecular Quality Controls, by Application USD Million (2021-2026)
  • Table 252. Mexico Molecular Quality Controls, by End Users USD Million (2021-2026)
  • Table 253. Mexico Molecular Quality Controls, by Analyte Type USD Million (2021-2026)
  • Table 254. Research Programs/Design for This Report
  • Table 255. Key Data Information from Secondary Sources
  • Table 256. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Molecular Quality Controls: by Type USD Million (2015-2020)
  • Figure 5. Global Molecular Quality Controls: by Application USD Million (2015-2020)
  • Figure 6. Global Molecular Quality Controls: by End Users USD Million (2015-2020)
  • Figure 7. Global Molecular Quality Controls: by Analyte Type USD Million (2015-2020)
  • Figure 8. South America Molecular Quality Controls Share (%), by Country
  • Figure 9. Asia Pacific Molecular Quality Controls Share (%), by Country
  • Figure 10. Europe Molecular Quality Controls Share (%), by Country
  • Figure 11. MEA Molecular Quality Controls Share (%), by Country
  • Figure 12. North America Molecular Quality Controls Share (%), by Country
  • Figure 13. Global Molecular Quality Controls share by Players 2020 (%)
  • Figure 14. Global Molecular Quality Controls share by Players (Top 3) 2020(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. SeraCare Life Sciences Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. SeraCare Life Sciences Inc. (United States) Revenue: by Geography 2020
  • Figure 18. ZeptoMetrix Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. ZeptoMetrix Corporation (United States) Revenue: by Geography 2020
  • Figure 20. Bio-Rad Laboratories Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Bio-Rad Laboratories Inc. (United States) Revenue: by Geography 2020
  • Figure 22. Microbiologics Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 23. Microbiologics Inc. (United States) Revenue: by Geography 2020
  • Figure 24. Thermo Fisher Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 25. Thermo Fisher Scientific (United States) Revenue: by Geography 2020
  • Figure 26. Maine Molecular Quality Controls Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Maine Molecular Quality Controls Inc. (United States) Revenue: by Geography 2020
  • Figure 28. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 29. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 30. Global Molecular Quality Controls: by Type USD Million (2021-2026)
  • Figure 31. Global Molecular Quality Controls: by Application USD Million (2021-2026)
  • Figure 32. Global Molecular Quality Controls: by End Users USD Million (2021-2026)
  • Figure 33. Global Molecular Quality Controls: by Analyte Type USD Million (2021-2026)
  • Figure 34. South America Molecular Quality Controls Share (%), by Country
  • Figure 35. Asia Pacific Molecular Quality Controls Share (%), by Country
  • Figure 36. Europe Molecular Quality Controls Share (%), by Country
  • Figure 37. MEA Molecular Quality Controls Share (%), by Country
  • Figure 38. North America Molecular Quality Controls Share (%), by Country
List of companies from research coverage that are profiled in the study
  • SeraCare Life Sciences Inc. (United States)
  • ZeptoMetrix Corporation (United States)
  • Bio-Rad Laboratories Inc. (United States)
  • Microbiologics Inc. (United States)
  • Thermo Fisher Scientific (United States)
  • Maine Molecular Quality Controls Inc. (United States)
  • Abbott Laboratories (United States)
Additional players considered in the study are as follows:
Roche Diagnostics (Switzerland) , Quidel Corporation (United States) , Qnostics Ltd. (United Kingdom)
Select User Access Type

Key Highlights of Report


Jan 2022 249 Pages 62 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Molecular Quality Controls Market Quantitative research analysis
Global Molecular Quality Controls Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Molecular Quality Controls market is expected to see a CAGR of 10.4% during projected year 2020 to 2026.
Top performing companies in the Global Molecular Quality Controls market are SeraCare Life Sciences Inc. (United States), ZeptoMetrix Corporation (United States), Bio-Rad Laboratories Inc. (United States), Microbiologics Inc. (United States), Thermo Fisher Scientific (United States), Maine Molecular Quality Controls Inc. (United States) and Abbott Laboratories (United States), to name a few.
North America is dominating the Molecular Quality Controls Market.

Know More About Global Molecular Quality Controls Market Report?

Have a Query? Click Here

Other Related Reports

Medical Specimen Bags Comprehensive Study by Type (Disposable, Reusable), Application (Hospitals, Clinics, Laboratory, Home Care, Other), Distribution Channel (Hospital Pharmacies, Online Pharmacies,...
$ 3350
Breast Surgery Retractors Comprehensive Study by Type (Single-arm Retractors, Double-arm Retractors), Application (Hospitals, Ambulatory Surgical Centers, Gynecology Clinics), Usage Types (Disposable...
$ 3650
Prebiotic Ingredient Comprehensive Study by Type (Inulin, Monosaccharides, Disaccharides, Oligosaccharides, Others), Application (Dairy Products, Dietary Supplements, Animal Feed, Functional Food & B...
$ 3750
Wound Healing Comprehensive Study by Type (Dressings, Bandages, Tropical Agents, Wound Closure Agents, Gauges & Sponges, Tapes, Therapy Devices), Application (Male, Female), Wound Type (Acute Wound, ...
$ 3350
Immuno-oncology Drugs Comprehensive Study by Type (Immune Checkpoint Inhibitors, Monoclonal Antibodies, Cytokine-Based Immunotherapy, Cancer Vaccines, CAR-T Cell Therapy), Application (Hospitals, Pha...
$ 3750
Testosterone Cypionate Comprehensive Study by Application (Primary Hypogonadism, Hypogonadotropic Hypogonadism, Late-Onset Hypogonadism), Route of Administration (Injectable, Parenteral), Active Ingr...
$ 3650